Literature DB >> 21973221

Analysis of the potential role of Apolipoprotein E polymorphism in genetic predisposition to spontaneous abortion.

Jitka Rynekrova1, Dita Kasparova, Vera Adamkova, Tomas Fait, Jaroslav A Hubacek.   

Abstract

PROBLEM: Up to 20% of pregnancies end in the first trimester by spontaneous abortion, but a significant number remains unexplained. The aim of this study is to investigate the role of variants within the gene for apolipoprotein E (APOE) in the genetic determination of spontaneous abortions. METHOD OF STUDY: We collected DNA from 410 tissue samples of spontaneous abortions, and APOE was genotyped by PCR-RFLP method. The frequencies were compared with a population sample of adults (N = 2606) and with a positive control (1060 women with at least two children).
RESULTS: The frequencies of the APOE genotypes in abortions (APOE2E2 + E3E2 = 0.132; APOE3E3 = 0.661; APOE3E4 + E4E4 = 0.195; APOE4E2 = 0.012) did not significantly differ (P = 0.604) from the frequencies in analyzed adult population study (APOE2E2 + E3E2 = 0.132; APOE3E3 = 0.686; APOE3E4 + E4E4 = 0.169; APOE4E2 = 0.014) or from the positive control (APOE2E2 + E3E2 = 0.133; APOE3E3 = 0.691; APOE3E4 + E4E4 =0.166; APOE4E2 = 0.010; P = 0.592).
CONCLUSION: Our study suggests that APOE may not be associated with spontaneous abortions in Caucasians.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21973221     DOI: 10.1111/j.1600-0897.2011.01071.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  2 in total

1.  Apolipoprotein E (Apo E) gene polymorphisms and recurrent pregnancy loss: a meta-analysis.

Authors:  Jie Li; Yang Chen; Hongbo Wu; Liuming Li
Journal:  J Assist Reprod Genet       Date:  2013-11-13       Impact factor: 3.412

2.  The role of connexin 37 polymorphism in spontaneous abortion.

Authors:  M Kníže; J Piťha; J A Hubacek; T Fait
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.